Miquel Gil-Gil

18PUBLICATIONS

166CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsMolecular targetsRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jul 15, 2026

Tumor-Infiltrating Lymphocytes as Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: Added Value of Morphological Characterization Beyond Quantification.

|Dec 12, 2025

Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López

|Oct 29, 2025

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial.

Iseult M Browne, Javier Pascual, Rosalind J Cutts

|Jul 09, 2025

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial.

Yash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil

|Apr 26, 2025

Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.

Helena Pla, Bartomeu Fullana, Anna Esteve

|Jan 25, 2025

Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

A Navarro-Sabaté, R Font, J A Espinàs

Pageof 3

Frequent Collaborators

Manuel Ruíz-Borrego

Sonia Pernas

Begoña Bermejo

Miguel Martín

Eva Maria Ciruelos Gil

4 joint publications

Angel L Guerrero-Zotano

4 joint publications

Mireia Margeli Vila

3 joint publications

Catalina Falo

3 joint publications

Maria Jesús Pla-Farnos

3 joint publications

Héctor Pérez-Montero

Frequent Collaborators

Manuel Ruíz-Borrego

Sonia Pernas

Begoña Bermejo

Miguel Martín